Atlas Trials

Meta-analysis in Post-marketing Surveillances for SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus

Clinical trial NCT02284269 · UNKNOWN

Trial details

NCT number
NCT02284269
Sponsor
Pharmaceuticals and Medical Devices Agency, Japan
Status
UNKNOWN
Study type
OBSERVATIONAL
Diabetes Mellitus, Type 2
Start date
2014-10-01
Primary completion
2020-05-01
Enrollment
18000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.